July 15, 2010
Drug Development Boot Camp
Cognigen will lecture at the Drug Development Boot Camp: An Intensive Two Day Course for Biotech and Pharma Company Executives to be held September 9 and 10, 2010.
May 26, 2010
PAGE Meeting in Berlin
Cognigen presented 2 posters at the 19th annual meeting of the Population Approach Group in Europe from June 8 to 11, 2010, in Berlin, Germany.
May 18, 2010
Cognigen Supports Institut Pasteur
Cognigen Corporation contributed to the 2010 Pasteur Foundation Gala, a fundraising event for the Institut Pasteur. The Gala was held May 17, 2010, in New York City.
April 20, 2010
Innovating and Imaginating
Check out an interview with Ted Grasela in the Pharma Quality by Design blog. Senior Editor Paul Thomas reviewed Ted’s lecture at the AAPS meeting in November 2009. He says, “I stopped by the Cognigen booth afterwards for a chat with Grasela and Cognigen colleagues, and came to appreciate their ideas of bringing more science to the development process.”
April 6, 2010
Hands-On NONMEM Workshop
A 3-day introductory workshop in population PK data analysis was presented May 13 to 15, 2010, by Cognigen Chief Scientific Officer Jill Fiedler-Kelly and other Cognigen scientists in conjunction with the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. This workshop provided a comprehensive understanding of the population PK approach to data analysis using formal lectures; interactive review of data, code, and data analysis results; and hands-on exercises. Participants learned how to code control streams, interpret the NONMEM output, and evaluate model results at individual computer terminals with assistance from the instructors.
March 3, 2010
Cognigen Poster at American Pain Society Meeting
The work of Cognigen scientists Joel Owen, PhD, RPh*, and Inger Darling, PhD, was presented in a poster at the 29th Annual Scientific Meeting of the American Pain Society from May 6 to 9, 2010, in Baltimore. The poster, Single-Dose and Steady-State Pharmacokinetics of MoxDuo™, a Dual-Opioid Formulation Containing a Fixed-Ratio of Morphine and Oxycodone, was presented by QRxPharma and Lifetree Clinical Research.
February 24, 2010
Cognigen Poster at ASCPT
Cognigen scientists Jill Fiedler-Kelly, MS, Elizabeth Ludwig, PharmD, and Qiang Lu, PhD, presented a poster entitled Population Pharmacokinetics of Dexmedetomidine (DEX) During Long-Term Continuous Infusion in Critically Ill Patients, at the ASCPT meeting March 17 to 20, 2010, in Atlanta, Georgia.
February 19, 2010
PMI Pharma SIG Meets in Philadelphia
Cynthia Walawander, MA, PMP, Executive Vice President and Chief Operating Officer of Cognigen Corporation, has been named Marketing Chair of the Project Management Institute’s Pharmaceutical Special Interest Group (PharmaSIG).
November 3, 2009
Cognigen at 2009 AAPS Meeting
Cognigen scientists Beth Ludwig, Qiang Lu, Jill Fiedler-Kelly, and Ted Grasela attended the 2009 Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS), November 8 to 12, 2009, in Los Angeles, California.
October 30, 2009
Cognigen & Janssen Poster at Psychiatric Congress
A poster describing the use of pharmacokinetic simulation to compare adherence patterns of patients with schizophrenia to two treatments with different PK profiles was presented at the U.S. Psychiatric and Mental Health Congress 2009 in Las Vegas, Nevada, November 2 to 5, 2009.
